Nemolizumab Approved for AD, Prurigo Nodularis in Europe ...Middle East

News by : (Medscape) -
The medication, also approved in the United States, is the first approved monoclonal antibody that specifically blocks the signaling of interleukin (IL)-31. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Nemolizumab Approved for AD, Prurigo Nodularis in Europe )

Also on site :

Most Viewed News
جديد الاخبار